Nasal Intubation Using the Blind Intubation Device (BID)

Nasal Intubation Using the Blind Intubation Device:a Prospective,Randomized,Controlled Comparison With the Direct Laryngoscope

The purpose of this study is to determine whether nasal tracheal intubation using Blind Intubation Device is safe and effective in anesthetized patients with Mallampati class 3

Study Overview

Status

Completed

Conditions

Detailed Description

The Blind Intubation Device (BID,Anhui Xiao Shan Hygienic Material Co.Ltd,Jixi County,China) is newly introduced for awake nasal intubation using a transillumination principle. For oral and maxillofacial surgery patients with anticipated difficult airways, the BID has a high rate of successful awake nasal intubation.Since the BID is more readily accessible,disposable and considerably less expensive,these advantages speak well for its use in China.However,to date,there is no study on its usage in anesthetized patients.The investigators hypothesized that a BID would be effective for nasal intubation in anesthetized patients with high Mallampati class and would result in fewer hemodynamic responses. To examine our hypothesis, the investigators would like to perform a prospective,randomized,controlled study to compare the effectiveness of the BID technique with a direct laryngoscope for nasal intubation in anesthetized patients with Mallampati class 3. The primary outcome measures are the hemodynamic changes during intubation. The investigators also would like to compare the intubation time required and associated airway complications in both groups as our second outcome.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200011
        • Department of Anesthesiology, Shanghai 9th People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 56 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA physical status 1-2
  • Scheduled for oral and maxillofacial surgery under general anesthesia with nasotracheal intubation
  • mallampati score 3

Exclusion Criteria:

  • ASA physical status 3-4
  • Patients with a history of intraoral,upper airway and neck surgeries
  • Patients with a history of chronic respiratory, cardiovascular or any other systemic diseases
  • morbid obesity
  • neck scars
  • mallampati score 4,inter-incisor distance<3cm, thyromental distance<6cm
  • unstable cervical spine
  • relevant drug allergy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Blind Intubation Device
nasal intubation using Blind Intubation Device after general anesthesia induction
Active Comparator: Direct laryngoscope
nasal intubation with macintosh laryngoscope after general anesthesia induction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Hemodynamic changes
Time Frame: 1 min before general anesthesia induction
1 min before general anesthesia induction
Hemodynamic changes
Time Frame: 5 min after general anesthesia induction
5 min after general anesthesia induction
Hemodynamic changes
Time Frame: 30s from nasal intubation start
30s from nasal intubation start
Hemodynamic changes
Time Frame: 1 min after nasal intubation
1 min after nasal intubation
Hemodynamic changes
Time Frame: 2 min after nasal intubation
2 min after nasal intubation
Hemodynamic changes
Time Frame: 3 min after nasal intubation
3 min after nasal intubation
hemodynamic changes
Time Frame: 4 min from nasal intubation start
4 min from nasal intubation start
hemodynamic changes
Time Frame: 5 min from nasal intubation start
5 min from nasal intubation start

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
intubation time required
Time Frame: 0 min after nasal intubation
from taking of the intubation device to successful intubation
0 min after nasal intubation
immediate associated airway complications
Time Frame: 5 min after nasal intubation
mucosal injury,dental injury,airway injury,bleeding, etc
5 min after nasal intubation
24h associated airway complications
Time Frame: 24h after intubation
sore throat, hoarseness, etc
24h after intubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jiang Hong, PhD,MD, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
  • Principal Investigator: Sun Yu, PhD,MD, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
  • Principal Investigator: Liu J Xing, MD, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
  • Principal Investigator: Xu Hui, MD, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
  • Principal Investigator: Huang Yan, MD, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
  • Study Director: Zhu Y Sen, MD, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

October 1, 2010

Study Completion (Actual)

October 1, 2010

Study Registration Dates

First Submitted

July 21, 2010

First Submitted That Met QC Criteria

July 26, 2010

First Posted (Estimate)

July 27, 2010

Study Record Updates

Last Update Posted (Estimate)

October 29, 2010

Last Update Submitted That Met QC Criteria

October 28, 2010

Last Verified

September 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • Shanghai 9th People's Hospital

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubation

Clinical Trials on Blind Intubation Device

Subscribe